Atlas Trials

A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection

Clinical trial NCT04585789 · COMPLETED

Trial details

NCT number
NCT04585789
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis B
Start date
2021-03-11
Primary completion
2023-02-08
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.